Castle Biosciences (CSTL) Other Gross PP&E Adjustments (2018 - 2025)
Castle Biosciences (CSTL) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with $94.5 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 99.99% to $94.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94.5 million through Dec 2025, up 99.99% year-over-year, with the annual reading at $94.5 million for FY2025, 99.99% up from the prior year.
- Other Gross PP&E Adjustments hit $94.5 million in Q4 2025 for Castle Biosciences, up from $86.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $94.5 million in Q4 2025 to a low of $421000.0 in Q1 2022.
- Historically, Other Gross PP&E Adjustments has averaged $29.3 million across 5 years, with a median of $16.0 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 95.64% in 2022 and later skyrocketed 2840.14% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at $3.0 million in 2021, then skyrocketed by 85.7% to $5.5 million in 2022, then skyrocketed by 206.24% to $16.8 million in 2023, then soared by 180.84% to $47.2 million in 2024, then skyrocketed by 99.99% to $94.5 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CSTL at $94.5 million in Q4 2025, $86.6 million in Q3 2025, and $74.1 million in Q2 2025.